Followers | 130 |
Posts | 13967 |
Boards Moderated | 6 |
Alias Born | 04/04/2008 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, November 04, 2008 2:54:53 PM
CEO of Traxxec, Inc. Responds to Shareholder Enquiries Regarding Reorganization
WYBUNBURY, England, Oct 30, 2008 (BUSINESS WIRE) -- Traxxec, Inc. (Pink Sheets: TRXX) (www.traxxec.com) announced an update to shareholders and the investment community in general regarding the reorganization of Traxxec, Inc. CEO Amy Scopes issued the following statement:
Due to the increased volume of investor and shareholder enquiry, I have decided to release certain updated information. I had anticipated issuing a progress report in February 2009, at the conclusion of my first year with the company; this would coincide with the completion of my first goals. However, I feel that I should make a series of press releases commencing next Monday 3rd November, to be followed by progress reports on an ad hoc basis through to 2009.
As I have stated to enquirers in reply, part of my remit has been the restructuring of the company and I am pleased to say that there has been reorganization and resource targeting for both the UK operation and progress made to establish an infrastructure in the U.S. This latter aspect -- fundamentally the appointment of U.S. representation and/or advocates -- although well advanced may need to change significantly due to commercial developments that I will report on later and hope to expand on fully early in 2009. In line with the above the name change to Traxxec Inc. was approved and the primary focus will remain on RFID packaging solutions and technical support when required in line with the Rexam agreement. However, business is dynamic and recent commercial enquiries may lead to developments that may change the proposed structure of the 'U.S. operation' but without detracting from its prime focus.
During the reorganization I can confirm:
-- that the patent annuities in the U.S. and Europe are current
-- that the patent remains licensed to Rexam Plc under a fifteen year agreement
-- all Intellectual Property is protected
-- Traxxec has retained Germane Systems and Ambry Associates in support of the agreement with Rexam
-- Traxxec has maintained its relationships with its technology and development partners
For further information on Traxxec's developments within the RFID/packaging industry and background to the technology and the product development please visit the website www.traxxec.com and the articles below.
http://www.in-pharmatechnologist.com/news/ng.asp?id=73668-rexam- traxxec-rfid-fda-pill-container
http://www.modplas.com/inc/mparticle.php?section=EWeekly& thefilename=eweekly07012007_22
http://www.ceepackaging.com/2007/01/24/rfid-solution-for- containers/
http://rfid.idtechex.com/knowledgebase/en/sectionintro.asp? sectionid=115
http://www.packaging-gateway.com/features/feature1317/
http://www.rexam.com/files/pdf/fce_presskit.pdf
(Due to their lengths, these URLs may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)
"I look forward to delivering positive commercial news over the coming weeks," stated Scopes.
SOURCE: Traxxec, Inc.
CONTACT:
For Traxxec, Inc. Keith Bryant 011+44(0) 845 396 8168
Copyright Business Wire 2008
-0-
KEYWORD: United Kingdom
Europe
INDUSTRY KEYWORD: Technology
Supply Chain Management
Hardware
Other Technology
Manufacturing
Packaging
Retail
SUBJECT CODE: Economic News/Analysis
Recent BRTX News
- BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 06/17/2024 11:05:00 AM
- Shares of Biotech MicroCap Rip on Licensing Talks • AllPennyStocks.com • 06/13/2024 03:40:00 PM
- BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/11/2024 08:28:30 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 06/11/2024 08:23:50 PM
- BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference • GlobeNewswire Inc. • 06/04/2024 12:50:00 PM
- BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice • GlobeNewswire Inc. • 05/24/2024 11:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:51:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:45:27 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 09:17:17 PM
- BioRestorative Therapies Provides First Quarter 2024 Business Update • GlobeNewswire Inc. • 05/14/2024 08:10:00 PM
- BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity • GlobeNewswire Inc. • 05/08/2024 11:30:00 AM
- BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 • GlobeNewswire Inc. • 04/30/2024 08:15:00 PM
- BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology • GlobeNewswire Inc. • 04/30/2024 11:30:00 AM
- Biotech Catches Major Premarket Bid Following FDA Clearance • AllPennyStocks.com • 04/16/2024 02:25:00 PM
- BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment • GlobeNewswire Inc. • 04/16/2024 11:45:00 AM
- BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 04/08/2024 11:45:00 AM
- BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants • GlobeNewswire Inc. • 04/03/2024 08:38:00 PM
- BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K • GlobeNewswire Inc. • 04/01/2024 11:45:00 AM
- BioRestorative Therapies to Participate in the 36th Annual ROTH Conference • GlobeNewswire Inc. • 03/11/2024 08:15:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/06/2024 09:34:22 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/15/2024 09:43:54 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/15/2024 09:40:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:27:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:25:23 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM